RetinalGenix Technologies Inc.
RTGN · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $65,772 | $91,999 | $92,982 | $28,705 |
| - Cash | $0 | $1 | $4 | $6 |
| + Debt | $56 | $56 | $56 | $57 |
| Enterprise Value | $65,828 | $92,055 | $93,035 | $28,755 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | -879% |
| EBITDA | -$567 | -$648 | -$586 | -$865 |
| % Margin | – | – | – | -865,188% |
| Net Income | -$569 | -$649 | -$587 | -$867 |
| % Margin | – | – | – | -867,027% |
| EPS Diluted | -0.03 | -0.035 | -0.032 | -0.048 |
| % Growth | 15.3% | -11.7% | 34.4% | – |
| Operating Cash Flow | -$104 | -$139 | -$187 | -$186 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$104 | -$139 | -$187 | -$186 |